Tradestie Institutional Equity Comparison Engine

CCCC vs CAMP โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CCCC Overall Edge

CCCC Captures Institutional Edge (2โ€“1 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to C4 Therapeutics, Inc. (CCCC) driven by superior Growth & Margin, Momentum & Technical while CAMP counters with relative strength in Options & Structure. Fundamentally, CCCC trades at N/M Forward P/E with -315.9% operating margin (-24.6% YoY revenue) versus CAMP at N/M Forward P/E and -991.8% operating margin (+138.9% YoY). In options structure, CCCC sits in BREAKDOWN (3rd %ile IV; Dealer Gamma Walls on Pro) against CAMP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CCCC N/M vs CAMP N/M Fwd P/E
Growth & Margin Winner CCCC
Op Margin -315.9% vs -991.8% ยท YoY -24.6% vs +138.9%
Momentum & Technical Winner CCCC
1Y +1.4% vs -2.4% ยท 52W Pos 23% vs 23%
Options & Structure Winner CAMP
BREAKDOWN (3rd %ile IV) vs UNCLASSIFIED (N/A IV)
CCCC NASDAQ
C4 Therapeutics, Inc.
Biological Products, (No Disgnostic Substances)
$2.50
-5.47% 1D
Market Cap $362.4M
1M Return -13.32%
1Y Return +1.42%
Forward P/E N/M
Unified AI Score
47.7 / 100 HOLD
Tech 33.0 Fund 51.0 Flow 64.0 Mom 60.0
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
1M Return +27.39%
1Y Return -2.44%
Forward P/E N/M
Unified AI Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CCCC +1.42% CAMP -2.44% Spread: +3.86 pp (CCCC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CCCC Revenue CAMP Revenue CCCC Op. Margin CAMP Op. Margin Margin Edge
FY2021 $50M N/A -179.4% N/A CCCC
FY2022 $30M N/A -416.6% N/A CCCC
FY2023 $20M $0M -669.8% -14822.6% CCCC
FY2024 $40M $0M -336.1% -8142.3% CCCC
FY2025 $40M $0M -320.5% -1502.4% CCCC

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CCCC (6) vs CAMP (2)
Institutional Metric CCCC CAMP Criterion Row Winner
Market Capitalization Scale $362.4M $238.5M Larger Scale CCCC
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -24.6% +138.9% Higher Growth CAMP
Operating Margin (TTM) Profitability -315.9% -991.8% Higher Margin CCCC
Net Profit Margin Profitability -282.2% 0.0% Higher Margin CAMP
Return on Equity (ROE) Capital Efficiency -47.6% -146.1% Higher ROE CCCC
52-Week Range Position Momentum 23% ($2โ€“$5) 23% ($3โ€“$8) Stronger Trend CCCC
Beta / 30D Volatility Risk Regime 1.46ฮฒ ยท 68% Vol 1.35ฮฒ ยท 94% Vol Lower Realized Risk CCCC
Unified Institutional Score Composite Signal 47.7 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite CCCC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CCCC vs CAMP Buy Guide
CCCC BREAKDOWN
118d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 3rd %ile
IV Regime Compressed (<25th %ile)
Live CCCC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CAMP Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CCCC nor CAMP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.